An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Clinical trial NCT02633683 · UNKNOWN
Trial details
- NCT number
- NCT02633683
- Sponsor
- XenoPort, Inc.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2024-05-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.